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Abstract
There is evidence that the major mediators of stress, i.e., catecholamines and glucocorticoids, play an important role in modulat-
ing thymopoiesis and consequently immune responses. Furthermore, there are data suggesting that glucocorticoids influence 
catecholamine action. Therefore, to assess the putative relevance of glucocorticoid-catecholamine interplay in the modulation 
of thymopoiesis we analyzed thymocyte differentiation/maturation in non-adrenalectomized and andrenalectomized rats sub-
jected to treatment with propranolol (0.4 mg·100 g body weight-1·day-1) for 4 days. The effects of β-adrenoceptor blockade on 
thymopoiesis in non-adrenalectomized rats differed not only quantitatively but also qualitatively from those in adrenalectomized 
rats. In adrenalectomized rats, besides a more efficient thymopoiesis [judged by a more pronounced increase in the relative 
proportion of the most mature single-positive TCRαβhigh thymocytes as revealed by two-way ANOVA; for CD4+CD8- F (1,20) = 
10.92, P < 0.01; for CD4-CD8+ F (1,20) = 7.47, P < 0.05], a skewed thymocyte maturation towards the CD4-CD8+ phenotype, 
and consequently a diminished CD4+CD8-/CD4-CD8+ mature TCRαβhigh thymocyte ratio (3.41 ± 0.21 in non-adrenalectomized 
rats vs 2.90 ± 0.31 in adrenalectomized rats, P < 0.05) were found. Therefore, we assumed that catecholaminergic modula-
tion of thymopoiesis exhibits a substantial degree of glucocorticoid-dependent plasticity. Given that glucocorticoids, apart from 
catecholamine synthesis, influence adrenoceptor expression, we also hypothesized that the lack of adrenal glucocorticoids 
affected not only β-adrenoceptor- but also α-adrenoceptor-mediated modulation of thymopoiesis. 
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It is well known that stress causes profound involution of 
the thymus gland (1). Increased secretion of catecholamines 
(CAs) and glucocorticoids (GCs), the end-products of the 
sympatho-adrenal and hypothalamo-pituitary-adrenal (HPA) 
axes, respectively, is the major trademark of the prototypical 
stress response (2,3). 
Ample evidence from denervation and pharmacological 
studies (4-6) has implicated CAs in the fine-tuning of thy-
mopoiesis (reviewed in Ref. 7). There is strong evidence that 
CAs exert thymus-dependent immunomodulatory effects via 
β-adrenoceptors (β-ARs) (reviewed in Refs. 7,8). However, 
there are data indicating that some of the effects of CAs on 
the thymus may be mediated via α-ARs (5,9). 
It has been demonstrated that both thymic lymphoid 
and non-lymphoid cells express glucocorticoid receptors 
(GRs) (10,11). Moreover, GCs have been implicated in the 
modulation of thymocyte development (12). 
The sympatho-adrenal and HPA axes often act in 
concert, with the signaling pathways of CAs and GCs 
being interwoven (2). Furthermore, GCs stimulate: i) CA 
biosynthesis and release (13), ii) β-AR gene expression and 
the receptor downstream intracellular signaling (14), and 
iii) α1- and α2-AR gene expression (15,16). On the other 
hand, noradrenaline affects GR expression in a receptor-
dependent manner (17). 
On the basis of the above considerations, we hypoth-
esized that CA modulation of thymopoiesis depends at 
least in part on circulating GC levels. To test this hypoth-
esis we analyzed thymocyte differentiation/maturation in 
the absence and in the presence of the main source of 
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endogenous GCs following a 4-day long β-AR blockade 
with propranolol.
Material and Methods
Animals
Adult male Dark Agouti rats bred at the Immunology Re-
search Centre “Branislav Janković” in Belgrade were used. 
Animals were housed under standard laboratory conditions 
with free access to food pellets and tap water. 
Chemicals and immunoconjugates
All monoclonal antibodies (mAbs): fluorescein-iso-
thiocyanate (FITC)-conjugated anti-CD4 (clone W3/25), 
phycoerythrin (PE)-conjugated anti-CD8 (clone MRC OX-8) 
and peridinin chlorophyll protein (PerCP)-conjugated anti-
TCRαβ (clone R73) were purchased from Serotec (UK). The 
appropriate IgG isotype-matched controls were obtained 
from BD Biosciences Pharmingen, USA.
Experimental protocol
Circulating glucocorticoids were removed by bilat-
eral adrenalectomy. Non-adrenalectomized (non-Adx) and 
adrenalectomized (Adx) rats were treated with propranolol 
hydrochloride (0.4 mg·100 g body weight-1·day-1, sc; 
Sigma Aldrich Gmbh, Germany) or saline for 4 consecu-
tive days. 
Rats were bilaterally Adx via a single dorsal incision 
under sodium phenobarbitone anesthesia (Nembutal, 40 
mg/kg, ip; Serva, Germany) and subjected to propranolol 
or saline treatment from day 4 post-adrenalectomy. All Adx 
animals were given 0.9% saline to drink. To avoid changes 
in corticosterone levels due to diurnal variation the rats were 
sacrificed between 9:00 and 10:00 am. All experimental 
procedures followed the principles of the European Com-
munity’s Council Directive of November 24, 1986 (86/609/
EEC) and were approved by the Immunology Research 
Center “Branislav Janković” Institutional Committee for 
Animal Care and Use. 
Thymic cell suspensions
The thymi were removed, dissected free of parathy-
mic lymph nodes and adherent membranous tissue and 
weighed. Cell suspensions were prepared by grinding the 
thymic tissue between the frosted ends of microscope 
slides and passing the ensuing suspensions through 
a fine nylon mesh. The single-cell suspensions were 
washed in ice-cold PBS containing 2% fetal calf serum 
(Gibco, USA) and 0.09% sodium azide (Sigma Aldrich; 
PS medium) and counted using an improved Neubauer 
hemocytometer.
Flow cytometry analysis
Analysis of CD4/CD8/TCRαβ expression. Aliquots of 
1 x 106 thymocytes were incubated simultaneously with 
FITC-conjugated anti-CD4, PE-conjugated anti-CD8 and 
PerCP-conjugated anti-TCRαβ mAbs for 30 min on ice in 
the dark. Thymocytes were then washed with PS medium, 
fixed in 0.5 mL 1% paraformaldehyde (Sigma Aldrich) 
in PBS and kept at 4°C until analysis. All samples were 
analyzed with a FACScan flow cytometer (Becton Dickin-
son Immunocytometry Systems, USA). Non-specific IgG 
isotype-matched controls were used for each fluorochrome 
type to define background staining, while dead cells and 
debris were excluded from analysis by selective anterior 
and right-angle scatter gating. Twenty thousand cells 
per sample were analyzed using the CellQuest Software 
(Becton Dickinson).
Cell cycle analysis. Briefly, 106-107 thymocytes in 0.4 
mL PBS were fixed by dropwise addition of 0.4 mL ice-cold 
absolute ethanol for 30 min, on ice. The cells were then 
centrifuged at 700 g for 5 min and 0.5 mL 1 mg/mL RNAse 
I-A (Sigma Aldrich) in PBS was added to the pellet. The 
samples were incubated at 37°C for 20 min. After incuba-
tion, 0.5 mL 40 µg/mL propidium iodide (Sigma Aldrich) 
in PBS was added, and the samples were incubated for 
the next 10 min at room temperature in the dark. Finally, 
the samples were passed through a fine nylon mesh and 
analyzed with a FACScan flow cytometer. 
Analysis of apoptotic cells. The cell susceptibility to 
apoptotic signals was analyzed in freshly isolated thymo-
cytes stained with merocyanine (MC) 540 (Sigma Aldrich) 
as described previously (6). Briefly, a 1 mg/mL stock solu-
tion of MC540 in twice-distilled water was filtered through 
a 0.22-nm filter and 5 µL MC540 solution was added to 
106-107 thymocytes before FACS analysis. Samples were 
analyzed with a FACScan flow cytometer.
Statistical analysis
Data are reported as means ± SEM. Statistical sig-
nificance of the differences in propranolol-induced thymic 
effects between non-Adx and Adx rats was determined by 
two-way ANOVA followed by the Bonferroni test for post 
hoc comparisons using the GraphPad Prism 5.0 software 
(GraphPad Software, Inc., USA). Differences were consid-
ered to be significant when P < 0.05. 
Results
Differential effect of propranolol on thymus weight 
and thymocyte yield in non-Adx and Adx rats
A 4-day propranolol treatment produced differential 
effects on thymus weight [adrenalectomy x propranolol 
interaction, F (1,20) = 4.281, P < 0.05] and thymocyte yield 
[adrenalectomy x propranolol interaction, F (1,20) = 4.279, P 
< 0.05] in non-Adx and Adx rats. Blockade of β-ARs affected 
neither thymus weight nor thymocyte yield in non-Adx rats, 
while it (P < 0.05) reduced the values of these parameters 
in Adx rats compared to the corresponding saline-injected 
controls (Table 1). 
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Differential effect of propranolol on thymocyte 
proliferative index in non-Adx and Adx rats
There was a significant [adrenalectomy x propranolol 
interaction, F (1,20) = 4.479, P < 0.05] difference in the 
effects of propranolol on the percentage of proliferating 
thymocytes (cells in the S/G2M phases of the cell cycle) 
in non-Adx and Adx rats. Namely, propranolol (P < 0.05) 
affected thymocyte proliferation in non-Adx rats, causing 
an increase in the percentage of proliferating cells, while it 
had no effect in Adx rats (Table 1).
Propranolol affected thymocyte apoptosis in Adx and 
non-Adx rats
Two-way ANOVA showed a significant effect of propra-
nolol on thymocyte apoptosis, but no significant propranolol 
x adrenalectomy interaction [F (1,20) = 3.486, P > 0.05]. 
Namely, irrespective of the presence of adrenal glands, 
propranolol (P < 0.01) increased the percentage of apoptotic 
thymocytes (Table 1).
Differential effect of propranolol on the distribution 
of thymocyte subsets as determined by CD4/CD8/
TCRαβ expression in Adx and non-Adx rats
As previously shown (7), twelve thymocyte subsets 
at distinct developmental stages were distinguished by 
plotting CD4 vs CD8 within each thymocyte population 
as determined by TCRαβ surface density (TCRαβhigh, 
TCRαβlow and TCRαβ-).
TCRαβ- thymocytes. Regarding the relative proportions 
of all TCRαβ- thymocyte subsets, two-way ANOVA revealed 
a significant propranolol x adrenalectomy interaction [for 
CD4-CD8-, F (1,20) = 6.67, P < 0.05; for CD4+CD8+, F (1,20) 
= 6.42, P < 0.05; for CD4+CD8-, F (1,20) = 35.73, P < 0.01; 
for CD4-CD8+, F (1,20) = 47.01, 0.01]. Propranolol increased 
the percentage of CD4-CD8- double-negative (DN) cells in 
both non-Adx and Adx rats (P < 0.01), but this effect was 
more pronounced in Adx rats (Figure 1Aa,Ba). Following 
propranolol treatment, the relative proportions of CD4+CD8+ 
double-positive (DP) and CD4+CD8- single-positive (SP) 
cells were decreased (P < 0.01 and P < 0.05, respectively), 
but to a greater extent in non-Adx rats (Figure 1Aa,Ba). 
Propranolol had opposing effect on the relative proportion 
of CD4-CD8+ SP cells in non-Adx and Adx rats. Compared 
with the corresponding saline-treated controls, the percent-
age of these cells was decreased (P < 0. 01) and increased 
(P < 0. 01) in non-Adx and Adx rats, respectively (Figure 
1Aa,Ba). 
TCRαβlow thymocytes. Compared with non-Adx rats, in 
Adx rats propranolol differently [F (1,20) = 66.97, P > 0.01] 
affected only the DP subset of TCRαβlow cells. Namely, 
although propranolol (P < 0.01) increased the percentage 
of DP cells in both non-Adx and Adx rats compared with 
their respective saline-injected controls, this effect was more 
pronounced in non-Adx rats (Figure 1Ab,Bb). Propranolol 
had no effect on the relative numbers of cells belonging to 
any of the other three subsets of TCRαβlow thymocytes in 
either non-Adx or Adx animals (Figure 1Ab,Bb). 
TCRαβhigh thymocytes. Regarding the relative propor-
tions of all thymocyte subsets, two-way ANOVA revealed a 
significant propranolol x adrenalectomy interaction [for DN, 
F (1,20) = 4.63, P < 0.05; for DP, F (1,20) = 30.76, P < 0.01; 
for CD4+CD8-, F (1,20) = 10.92, P < 0.01; for CD4-CD8+, 
F (1,20) = 7.47, P < 0.05]. Propranolol (P < 0.01) reduced 
the percentage of DP thymocytes in non-Adx rats, but was 
ineffective in this respect in Adx rats (Figure 1Ac,Bc). On 
the other hand, although propranolol increased the rela-
tive proportions of CD4+CD8- (P < 0.01) and CD4-CD8+ 
(P < 0.05) SP cells in both non-Adx and Adx rats, this 
effect was more pronounced in Adx rats (Figure 1Ac, Bc). 
Furthermore, a reduced (P < 0.05) CD4+/CD8- cell ratio in 
propranolol-treated Adx rats (2.90 ± 0.31) compared with 
propranolol-treated non-Adx rats (3.41 ± 0.21) suggested 
a particularly pronounced effect of propranolol on the 
size of the CD4-CD8+ SP cell subset in Adx rats. In addi-
Table 1. Differential effect of 4-day propranolol treatment on thymus weight, thymocyte yield 
and proliferative index in adrenalectomized (Adx) and non-Adx adult rats compared to the 
corresponding saline-treated controls.
Non-Adx rats Adx rats
Saline Propranolol Saline Propranolol
Thymus weight (g) 0.18 ± 0.006 0.17 ± 0.016 0.31 ± 0.016 0.25 ± 0.006*
Thymocyte yield (x 107) 19.89 ± 1.03 17.76 ± 0.27 62.29 ± 2.01 57.66 ± 0.95*
Proliferative index (%) 9.32 ± 0.38 13.48 ± 0.47* 16.34 ± 0.21 19.33 ± 1.87
Apoptosis (%) 8.75 ± 0.51 12.36 ± 0.34* 3.27 ± 0.35 4.98 ± 0.35*
Data are reported as means ± SEM (N = 6). Proliferative index = percent of cells in the S/G2M 
phases of the cell cycle. Apoptosis was measured with merocyanine 540. *P < 0.05 compared 
to the corresponding saline-treated controls (two-way ANOVA followed by the Bonferroni test 
for post hoc comparisons).
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tion, in Adx rats, propranolol increased the percentage of 
DN cells compared to saline-injected rats, while in non-Adx 
rats the percentage of these cells was unaltered following 
propranolol treatment (Figure 1Ac,Bc).
Discussion
The results of the present study showed that a 4-day 
propranolol treatment has a differential effect on thymus 
weight and thymocyte yield in non-Adx and Adx rats. Pro-
pranolol (most likely due to a differential effect on thymocyte 
proliferation) reduced both thymic weight and cellularity 
in Adx, with no similar effect in non-Adx rats. Since the 
adrenaline level in adult rat thymus has been found to be 
below detection level (18), it may be assumed that the thy-
mic changes in Adx rats mainly reflected a lack of adrenal 
GCs. This view is further supported by data showing that: 
i) noradrenergic nervous fibers represent the main source 
of CAs in the thymus (7,8), and ii) surgical stress does not 
affect any of the thymopoiesis parameters analyzed (12). 
The ineffectiveness of propranolol in enhancing thymocyte 
proliferation in the absence of adrenal GCs may be explained 
by the fact that thymocyte proliferation was measured in 
an unfractionated thymocyte suspension. Namely, in Adx 
rats, an impaired α2-AR-mediated stimulatory effect of CA 
on proliferation of an α2-AR expressing thymocyte subset 
[due to reduced α2-AR expression (16)], could mask the 
enhancing effects of the β-AR blockade on the proliferation 
of the thymocyte subset expressing β-ARs. 
The analysis of thymocyte subset composition showed 
Figure 1. Differential effect of 4-day propranolol treatment on thymocyte subset distribution in non-adrenalectomized (non-Adx; panel 
A) and Adx adult male Dark Agouti rats (panel B). The histograms indicate the relative numbers of thymocyte subsets determined by 
CD4/CD8 expression with (a) undetectable (b) low and (c) high levels of TCRαβ in non-Adx and Adx rats treated with propranolol or 
saline. Data are reported as means ± SEM (N = 6). DN = CD4-CD8-, double-negative; DP = CD4+CD8+, double-positive. *P < 0.05 
compared to the corresponding saline-treated control (two-way ANOVA followed by the Bonferroni test for post hoc comparisons).
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that propranolol treatment led to an overrepresentation of 
the least mature DN TCRαβ- thymocytes in non-Adx rats, 
followed by the underrepresentation of their DP TCRαβ- 
progeny. Furthermore, in these rats, propranolol treat-
ment increased the relative proportion of DP TCRαβlow 
thymocytes (the cells entering positive selection) and the 
most mature SP TCRαβhigh thymocytes, while it reduced 
that of intermediate DP TCRαβhigh cells (the cells that had 
just undergone positive selection). Taken together, these 
findings suggest a decelerated transition from the DN 
TCRαβ- to the DP TCRαβ- developmental stage, followed 
by increased positive/reduced negative selection and ac-
celerated post-selection differentiation/maturation. In view 
of the fact that: i) propranolol abrogates dose-dependent 
noradrenaline-induced destabilization of Thy-1 mRNA in 
T-cell lines (19) and increases Thy-1 surface expression 
on thymocytes (7), and ii) Thy-1-/- mice exhibit reduced 
positive/exaggerated negative selection and consequently a 
reduced proportion of mature SP cells (20), the alterations in 
thymocyte development in propranolol-treated non-Adx rats 
may be related at least in part to increased Thy-1 surface 
expression (data not shown).
In view of the fact that GCs increase CA synthesis and 
β-AR signaling (14,15), a more efficient β-AR blockade, 
and therefore more pronounced changes in thymopoiesis 
may be expected in thymi of Adx rats. Indeed, compared 
with non-Adx rats, in Adx rats propranolol caused a more 
pronounced increase in the proportion of the most immature 
DN TCRαβ- and the most mature (in particular CD4-CD8+) 
SP TCRαβhigh thymocytes. In addition, adrenalectomy 
partly (DP TCRαβ- and DP TCRαβlow cells) or entirely (DP 
TCRαβhigh cells) abrogated the effects of β-AR blockade 
on the relative proportion of DP thymocytes. Generally, a 
more pronounced increase in the proportion of the least 
mature DN TCRαβ- cells than in the proportion of the most 
mature SP TCRαβhigh cells following propranolol treatment 
in Adx compared with non-Adx rats may suggest a more 
pronounced increase in positive selection/decrease in 
negative selection. Furthermore, it may be speculated that 
the alteration in thymocyte selection (most likely reflecting 
a greater increase in Thy-1 thymocyte surface density due 
to a more efficient β-AR blockade) in Adx rats not only 
compensated decelerated transition from the early DN 
TCRαβ- to the DP TCRαβ- developmental step but provided 
a substantially more pronounced increase in the relative 
proportion of the most mature SP thymocytes in these rats 
compared with non-Adx rats. 
Moreover, given that: i) GCs enhance CA and α1-AR 
expression (14,16), and ii) the blockade of α1-ARs prevents 
the transition from the DN to DP thymocyte developmental 
steps and favors post-selection maturation towards ma-
ture CD4+CD8- SP cells (6), it is reasonable to assume 
that a more pronounced increase in the proportion of DN 
TCRαβ- cells and CD4-CD8+ SP TCRαβhigh cells following 
propranolol treatment in Adx rats compared with non-Adx 
rats reflected a substantially reduced α1-AR-mediated CA 
action. 
In conclusion, the present study pointed to GC-depen-
dent plasticity of CA-mediated fine-tuning of thymopoiesis, 
and indirectly suggested that GCs influence T-cell develop-
ment, not only by a direct action on thymocytes and thymic 
non-lymphoid cells (11,12), but also indirectly, affecting CA 
availability and/or AR sensitivity to CA signaling. 
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